Olanzapine Oral Soluble Film(Qilu Pharma)

奥氮平口溶膜（齐鲁制药）

Report date: 2025/07/11 10:41:16

Base Information

Drug NameOlanzapine Oral Soluble Film(Qilu Pharma)
Drug Alias Nameolanzapine奥兰扎平olanzapinum奥兰氮平olanzapina +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D2 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists
TargetsDopamine D1 receptorDopamine D2 receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsSchizophreniaBipolar Disorder
Approved Indications in ChinaSchizophreniaBipolar Disorder
Original Approved Country/TerritoryMainland China
Original Approved Date2021/01/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG